January 18, 2018 / 7:08 AM / in 10 months

BRIEF-PCI Biotech Holding Extends Preclinical Research Collaboration

Jan 18 (Reuters) - PCI BIOTECH HOLDING ASA:

* EXTENDING PRECLINICAL RESEARCH COLLABORATION WITH UNDISCLOSED TOP-10 PHARMA COMPANY, INITIATED IN SEPTEMBER 2015​

* WILL EVALUATE DATA GENERATED AND EXPLORE POTENTIAL FOR FURTHER PARTNERSHIP BASED ON OUTCOME

* - EXTENDED EVALUATION PERIOD SPANS OVER 6 MONTHS, UNTIL THE END OF JUNE 2018, AND MAY BE FURTHER EXTENDED Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below